Read More
Folic acid supplementation mitigates risk of neural tube defects linked to HIV drug
Dolutegravir is a preferred medication for treating HIV infection, but it recently has been linked to a 6- to 9-fold increase in the risk for neural tube defects among babies born to mothers receiving the drug during early gestation.
Read More
>>Hollywood's Exotic Secret For Healthy Weight Loss
Read More
- Impact of a pan-sarbecovirus dendritic-cell targeting vaccine on SARS-CoV-2 variants
- Combination of rifampicin and resveratrol helps stop dementia, finds study
- Researchers discover antibodies that neutralize omicron and other SARS-CoV-2 variants
- SARS-CoV-2 omicron variant may be less severe than the delta variant
Subscribe to:
Post Comments (Atom)
0 Response to "Folic acid supplementation mitigates risk of neural tube defects linked to HIV drug"
Post a Comment